TaiShang
ELITE MEMBER
- Joined
- Apr 30, 2014
- Messages
- 27,848
- Reaction score
- 70
- Country
- Location
The Public Health Institute of Chile (ISP) on Wednesday approved the emergency use of CoronaVac, a vaccine against the novel coronavirus disease developed by Beijing-based biopharmaceutical company Sinovac.
The decision was made on grounds of good results obtained "regarding the manufacturing quality and the strains being developed in the manufacture of this vaccine," said acting director of the ISP, Heriberto Garcia.
Chile has logged 680,740 COVID-19 cases and 17,594 deaths so far.
news.cgtn.com
The decision was made on grounds of good results obtained "regarding the manufacturing quality and the strains being developed in the manufacture of this vaccine," said acting director of the ISP, Heriberto Garcia.
Chile has logged 680,740 COVID-19 cases and 17,594 deaths so far.
Chile approves emergency use of China's Sinovac COVID-19 vaccine
The Public Health Institute of Chile (ISP) on Wednesday approved the emergency use of CoronaVac, a vaccine against the novel coronavirus disease developed by Beijing-based biopharmaceutical company Sinovac.
news.cgtn.com
